Pramod N Nehete Selected Research

Viremia

1/2011	Functional impairment of central memory CD4 T cells is a potential early prognostic marker for changing viral load in SHIV-infected rhesus macaques.
1/2008	Selective induction of cell-mediated immunity and protection of rhesus macaques from chronic SHIV(KU2) infection by prophylactic vaccination with a conserved HIV-1 envelope peptide-cocktail.
3/2005	Protection by dendritic cells-based HIV synthetic peptide cocktail vaccine: preclinical studies in the SHIV-rhesus model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pramod N Nehete Research Topics

Disease

5	Infections 01/2023 - 12/2002
3	Inflammation (Inflammations) 01/2023 - 01/2018
3	Communicable Diseases (Infectious Diseases) 01/2020 - 01/2005
3	Neoplasms (Cancer) 12/2019 - 04/2007
3	Viremia 01/2011 - 03/2005
2	Type 2 Diabetes Mellitus (MODY) 02/2022 - 01/2018
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2020
2	Vesicular Stomatitis 11/2018 - 10/2014
2	Acquired Immunodeficiency Syndrome (AIDS) 03/2005 - 02/2004
2	Virus Diseases (Viral Diseases) 12/2004 - 12/2002
1	Foreign Bodies (Foreign Body) 01/2023
1	Hypoxia (Hypoxemia) 12/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2022
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2021
1	Dementia (Dementias) 01/2021
1	Amyloid Plaque 01/2021
1	Chronic Disease (Chronic Diseases) 10/2020
1	HIV Infections (HIV Infection) 01/2019
1	Adenoviridae Infections (Adenovirus Infections) 11/2018
1	Obesity 01/2018
1	Cardiotoxicity 01/2018
1	Weight Loss (Weight Reduction) 01/2018
1	Malaria 01/2017
1	Dyslipidemias (Dyslipidemia) 04/2016
1	Persistent Infection 01/2011
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2007
1	Uterine Cervical Dysplasia 04/2007

Drug/Important Bio-Agent (IBA)

7	Peptides (Polypeptides)IBA 01/2008 - 12/2002
6	VaccinesIBA 11/2018 - 02/2004
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2002
3	AntigensIBA 11/2018 - 12/2004
2	OligodeoxyribonucleotidesIBA 01/2021 - 01/2020
2	Indicators and Reagents (Reagents)IBA 01/2011 - 12/2002
1	Urocanic AcidIBA 01/2023
1	islatravirIBA 01/2023
1	FumaratesIBA 01/2023
1	SaltsIBA 01/2023
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	CpG ODN 2006IBA 01/2021
1	CPG-oligonucleotideIBA 01/2021
1	Scavenger Receptors (Scavenger Receptor)IBA 12/2019
1	LipidsIBA 12/2019
1	Positive Transcriptional Elongation Factor BIBA 01/2019
1	HLA-DR Antigens (HLA-DR)IBA 01/2019
1	tat Gene Products (tat Protein)IBA 01/2019
1	Glycoproteins (Glycoprotein)IBA 11/2018
1	GC 1 compoundIBA 01/2018
1	Insulin (Novolin)FDA Link 01/2018
1	FenbendazoleIBA 01/2018
1	Nonesterified Fatty Acids (NEFA)IBA 04/2016
1	CholesterolIBA 04/2016
1	Triglycerides (Triacylglycerol)IBA 04/2016
1	OvalbuminIBA 10/2014
1	gag Gene Products (gag Protein)IBA 10/2014
1	oleandrinIBA 01/2013
1	Cardiac GlycosidesIBA 01/2013
1	Interleukin-2 (IL2)IBA 01/2011
1	Neutralizing AntibodiesIBA 01/2008
1	Freund's AdjuvantIBA 01/2008
1	CD4 Antigens (CD4 Antigen)IBA 06/2007
1	Viral Envelope ProteinsIBA 06/2007
1	Amino Acids FDA Link 06/2007
1	Oncogene Proteins (Oncogene Protein)IBA 04/2007
1	Papillomavirus Vaccines (HPV Vaccines)IBA 04/2007
1	GlycosphingolipidsIBA 12/2002

Therapy/Procedure

2	Therapeutics 02/2022 - 01/2021
1	Transplantation 12/2022
1	Immunomodulation 01/2021
1	Art Therapy 10/2020
1	Heterologous Transplantation (Xenotransplantation) 01/2020